Drug intelligence / Profile preview

autologous fat tissue

Development stage
Phase 2
Lead developer
Lipogems International
Modality
Cell Therapies
Administration
Subcutaneous, Intramuscular, Intraarticular, Intralesional, Percutaneous
01

Overview

Autologous fat tissue is a patient-derived adipose tissue used as a therapeutic grafting material for reconstructive, aesthetic, and regenerative purposes. The procedure, commonly known as autologous fat transfer (AFT) or lipofilling, involves harvesting adipose tissue via liposuction (typically from the abdomen or thighs), processing the lipoaspirate through centrifugation or filtration (using systems such as PureGraft), and reinjecting it into target recipient sites. In breast reconstruction, it serves as a minimally invasive alternative or adjunct to implants, often combined with external expansion devices (e.g., Brava or EveBra) to improve graft survival and skin quality, particularly in irradiated tissues. Beyond volume restoration, autologous fat tissue is utilized to correct contour deformities like temporal hollowing, alleviate persistent neuropathic pain following mastectomy (PPBCT), and treat symptomatic knee osteoarthritis. Its therapeutic efficacy is attributed to both its physical volume-filling properties and the regenerative potential of its constituent adipose-derived stem cells (ADSCs), which facilitate tissue repair, angiogenesis, and immunomodulation.

Other names
autologous fat transferAFTautologous fat graftinglipofillingautogenous fat graftinglipostructureadipose tissue grafting

Beyond the preview

Go deeper on autologous fat tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous fat tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call